New York, NY, March 15, 2019 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Pharmacovigilance and Drug Safety Software Market by Functionality (ADR Reporting Software, Drug Safety Audits Software, Issue Tracking Software, and Fully Integrated Software), by Delivery Mode (On-Premises and On-Demand), and by End-User (Pharma & Biotech Companies, Contract Research Organizations (CROS), Business Process Outsourcing (BPO) Firms, and Other Pharmacovigilance Service Providers): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025”. According to the report, the global pharmacovigilance and drug safety software market was valued at approximately at USD 141 million in 2018 and is expected to generate around USD 223 million by 2025, at a CAGR of around 6.7% between 2019 and 2025.
According to the World Health Organization (WHO), pharmacovigilance is the science and activities related to the understanding, evaluation, detection, and prevention of adversarial reactions to medications or problems related to medicine. The scope and definition of pharmacovigilance have evolved to identify the significance of a systems approach for improving and monitoring the harmless and safe use of medicines.
Browse through 54 Tables & 22 Figures spread over 110 Pages and in-depth TOC on “Global Pharmacovigilance and Drug Safety Software Market Size, Share, Segments, Industry Applications, Analysis and Forecast, 2018–2025”.
Request Free Sample Report of Global Pharmacovigilance and Drug Safety Software Market Report @ https://www.zionmarketresearch.com/sample/pharmacovigilance-drug-safety-software-market
Pharmacovigilance and drug safety software or tools aid in classifying, reviewing, and forming pharmacovigilance data. This software also helps in the formation of repots related to adverse medical events. Additionally, the pharmacovigilance software is majorly used by biotech and pharmaceutical organizations, business process outsourcing firms (BPOs), contract research organizations (CROs), and many other pharmacovigilance service providers. Pharmacovigilance globalization with extensive availability and access of the internet is likely to fuel the global pharmacovigilance and drug safety software market in the future. Moreover, the augmenting adoption of pharmacovigilance software by numerous outsourcing companies will also serve as a huge growth opportunity for the global pharmacovigilance and drug safety software market over the forecast timespan.
The global pharmacovigilance and drug safety software market is segmented on the basis of functionality, delivery mode, and end-user. Based on functionality, the market is segmented into drug safety audits software, ADR reporting software, fully integrated software, and issue tracking software. The fully integrated software segment is expected to register the highest growth over the forecast time period, owing to the increasing need to prevent errors in database management regarding medicines.
Download Free Report PDF Brochure: https://www.zionmarketresearch.com/requestbrochure/pharmacovigilance-drug-safety-software-market
By delivery mode, the market is segmented into on-premises and on-demand. The on-premises segment is anticipated to hold the largest market share, owing to its rising adoption by large pharmaceutical companies as it encompasses the installation of solutions and services on desktops within the organizational premises. Alternatively, the on-demand segment is anticipated to register the highest CAGR globally.
By end-user, the market is segmented into contract research organizations (CROS), business process outsourcing (BPO) firms, pharma and biotech companies, and other pharmacovigilance service providers. The pharma and biotech companies are estimated to dominate the global pharmacovigilance and drug safety software market over the forecast timeline, owing to the high software adoption of to aid clinical trial activities and decrease medical expenditures. The contract research organizations (CRO’S) are anticipated to show the highest CAGR in the global pharmacovigilance and drug safety software market, owing to increasing outsourcing activities in pharmaceutical and biotech companies.
Request Discount on This Report: https://www.zionmarketresearch.com/requestdiscount/pharmacovigilance-drug-safety-software-market
By region, North America is anticipated to lead the global pharmacovigilance and drug safety software market over the forecast period, owing to the large base of pharmaceutical and biotechnology companies in the region. The U.S. is expected to dominate the North American pharmacovigilance and drug safety software market and grow at an optimum rate over the forecast period, owing to the high adoption rate of PV software and a high number of clinical trials being conducted in the region.
Europe is anticipated to hold the second largest position in the global pharmacovigilance and drug safety software market and show remarkable growth in the future. This regional growth can be due to the high rate of clinical trials and increasing contract research manufacturing coupled with favorable regulations. Germany accounted for a major share of the Europe pharmacovigilance and drug safety software market, due to the high acceptance of newer technologies in Germany and high disposable income.
Browse the full “Pharmacovigilance and Drug Safety Software Market by Functionality (ADR Reporting Software, Drug Safety Audits Software, Issue Tracking Software, and Fully Integrated Software), by Delivery Mode (On-Premises and On-Demand), and by End-User (Pharma & Biotech Companies, Contract Research Organizations (CROS), Business Process Outsourcing (BPO) Firms, and Other Pharmacovigilance Service Providers): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025” Report at https://www.zionmarketresearch.com/report/pharmacovigilance-drug-safety-software-market
The Asia Pacific pharmacovigilance and drug safety software market is anticipated to record lucrative growth over the projected time period, owing to the increasing penetration of large and small pharmaceutical companies in the region, growing awareness about drug safety management, and rising adoption of pharmacovigilance software. India and China are expected to register a higher CAGR in this regional, owing to the increasing number of clinical trials and the rising number of contract research organizations and business process outsourcing firms in the region.
The Latin American market growth is expected, led by Brazil, will be driven by high unmet medical needs and increasing awareness, knowledge, and benefits about pharmacovigilance and drug safety software. The Middle Eastern and African market is likely to witness noticeable growth with the increasing number of clinical trials in African countries and improved government initiatives.
Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/pharmacovigilance-drug-safety-software-market
Some key players of the global pharmacovigilance and drug safety software market include Oracle Corporation, ArisGlobal LLC, AB Cube, Max Delivery, Relsys, Sparta Systems, Inc., United BioSource Corporation, EXTEDO GmbH, and Ennov Solutions, Inc., among others.
Request customized copy of report @ https://www.zionmarketresearch.com/custom/3172
This report segments the global pharmacovigilance and drug safety software market into:
Global Pharmacovigilance and Drug Safety Software Market: Functionality Analysis
- ADR Reporting Software
- Drug Safety Audits Software
- Issue Tracking Software
- Fully Integrated Software
Global Pharmacovigilance and Drug Safety Software Market: Delivery Mode Analysis
- On-Premises
- On-Demand
Global Pharmacovigilance and Drug Safety Software Market: End-User Analysis
- Pharma and Biotech Companies
- Contract Research Organizations (CROS)
- Business Process Outsourcing (BPO) Firms
- Other Pharmacovigilance Service Providers
Global Pharmacovigilance and Drug Safety Software Market: Regional Analysis
- North America
- The U.S.
- Europe
- UK
- France
- Germany
- Asia Pacific
- China
- Japan
- India
- Latin America
- Brazil
- The Middle East and Africa
Related Reports:
- Diabetic Foot Ulcers and Pressure Ulcers Market: https://www.zionmarketresearch.com/report/diabetic-foot-ulcers-and-pressure-ulcers-market
- Immunotherapy Drugs Market: https://www.zionmarketresearch.com/report/immunotherapy-drugs-market
- Gene Therapy Market: https://www.zionmarketresearch.com/report/gene-therapy-market
- Bile Duct Cancer Drug Market: https://www.zionmarketresearch.com/report/bile-duct-cancer-drug-market
- Medical Marijuana Market: https://www.zionmarketresearch.com/report/medical-marijuana-market
About Us:
Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research
Follow Us Twitter: https://twitter.com/zion_research
Blog: http://zmrindustryjournal.us | http://zmrresearchnews.us | http://zmrmarketjournal.com | https://zmrnewsjournal.us | http://zmrnewsmagazine.com | https://zmrnewsblog.com
Contact Us:
Joel John
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com
Blog: http://zmrblog.com